Biogen, Inc. (BIIB)
219.88
-2.94
(-1.32%)
USD |
NASDAQ |
Oct 02, 16:00
219.10
-0.78
(-0.35%)
After-Hours: 20:00
Biogen Max Drawdown (5Y) : 72.66% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 72.66% |
| August 31, 2026 | 72.66% |
| July 31, 2026 | 72.66% |
| June 30, 2026 | 72.66% |
| May 31, 2026 | 72.66% |
| April 30, 2026 | 72.66% |
| March 31, 2026 | 72.66% |
| February 28, 2026 | 72.66% |
| January 31, 2026 | 72.66% |
| December 31, 2025 | 72.66% |
| November 30, 2025 | 72.66% |
| October 31, 2025 | 72.66% |
| September 30, 2025 | 72.66% |
| August 31, 2025 | 72.66% |
| July 31, 2025 | 72.66% |
| June 30, 2025 | 72.66% |
| May 31, 2025 | 72.66% |
| April 30, 2025 | 72.66% |
| March 31, 2025 | 67.83% |
| February 28, 2025 | 67.83% |
| January 31, 2025 | 66.11% |
| December 31, 2024 | 64.68% |
| November 30, 2024 | 62.52% |
| October 31, 2024 | 58.04% |
| September 30, 2024 | 54.78% |
| Date | Value |
|---|---|
| August 31, 2024 | 54.78% |
| July 31, 2024 | 54.78% |
| June 30, 2024 | 54.78% |
| May 31, 2024 | 54.78% |
| April 30, 2024 | 54.78% |
| March 31, 2024 | 54.78% |
| February 29, 2024 | 54.78% |
| January 31, 2024 | 54.78% |
| December 31, 2023 | 54.78% |
| November 30, 2023 | 54.78% |
| October 31, 2023 | 54.78% |
| September 30, 2023 | 54.78% |
| August 31, 2023 | 54.78% |
| July 31, 2023 | 54.78% |
| June 30, 2023 | 54.78% |
| May 31, 2023 | 54.78% |
| April 30, 2023 | 54.78% |
| March 31, 2023 | 54.78% |
| February 28, 2023 | 54.78% |
| January 31, 2023 | 54.78% |
| December 31, 2022 | 54.78% |
| November 30, 2022 | 54.78% |
| October 31, 2022 | 54.78% |
| September 30, 2022 | 54.78% |
| August 31, 2022 | 54.78% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Ionis Pharmaceuticals, Inc. | 70.27% |
| AbbVie, Inc. | 21.89% |
| Gilead Sciences, Inc. | 26.58% |
| Regeneron Pharmaceuticals, Inc. | 59.69% |
| Amgen, Inc. | 24.86% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -9.114 |
| Beta (5Y) | 0.0920 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 29.73% |
| Historical Sharpe Ratio (5Y) | -0.2756 |
| Historical Sortino (5Y) | -0.5627 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 11.56% |